Effects of serum sodium and chloride levels in the outcome of critically ill pediatric patients in the post-operative period of liver transplantation

Imagem de Miniatura
Arquivos
art_LUGLIO_Effects_of_serum_sodium_and_chloride_levels_in_2023.PDF (1.04 MB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
FRANCA, Gardenia Morais
Citação
BMC NEPHROLOGY, v.24, n.1, article ID 141, 9p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundSodium and chloride disturbances have attracted increasing attention in recent years. Many pathophysiological effects are associated with hyperchloremia, including reduction in mean arterial pressure and acute renal disease. Pediatric patients undergoing liver transplantation are at risk of developing various electrolyte and biochemical abnormalities, with an impact on their postoperative outcomes.ObjectiveTo analyze the impacts of serum sodium and chloride levels on prognosis of Pediatric Liver Transplant receptors.MethodsThis was a retrospective analytical observational study performed in a single transplant reference center in Sao Paulo, Brazil. Included patients were pediatric patients who underwent liver transplantation between January 2015 and July 2019. Statistical regression analysis and General Estimating Equations analysis were performed to evaluate the impacts of sodium and chloride disturbances on the development of acute renal failure and mortality.ResultsA total of 143 patients were included in this study. The main diagnosis was Biliary Atresia (62.9%). Twenty-seven patients died (18.9%), and graft dysfunction was the main cause of death (29.6%). The only variable individually associated with 28-days mortality was PIM-3 score (HR 1.59, CI 95% 1.165-2.177, p = 0.004). Forty-one patients (28.6%) developed moderate or severe AKI. PIM-3 score (OR 3.052, 95% CI 1.56-5.97, p = 0.001), hypernatremia (OR 3.49, 95% CI 1.32-9.23, p = 0.012), and hyponatremia (OR 4.24, 95% CI 1.52-11.85, p = 0.006) were independently associated with the development of moderate/severe AKI.ConclusionsIn pediatric patients after liver transplantation, PIM-3 score, and abnormal serum sodium levels were correlated with AKI development.
Palavras-chave
Sodium, Chloride, Liver transplant, Acute renal failure
URI
https://observatorio.fm.usp.br/handle/OPI/53993
Referências
  1. Berend K, 2012, EUR J INTERN MED, V23, P203, DOI 10.1016/j.ejim.2011.11.013
  2. Bidani A, 1998, LUNG, V176, P111, DOI 10.1007/PL00007593
  3. Combs S, 2014, AM J KIDNEY DIS, V63, P294, DOI 10.1053/j.ajkd.2013.09.017
  4. Dawwas MF, 2007, LIVER TRANSPLANT, V13, P1115, DOI 10.1002/lt.21154
  5. Elisofon SA, 2020, PEDIATR TRANSPLANT, V24, DOI 10.1111/petr.13605
  6. Ferah O, 2019, TRANSPL P, V51, P2486, DOI 10.1016/j.transproceed.2019.01.179
  7. Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0
  8. Iacob S, 2021, TRANSPL IMMUNOL, V69, DOI 10.1016/j.trim.2021.101448
  9. Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555
  10. Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003
  11. Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789
  12. Lenci I, 2020, WORLD J HEPATOL, V12, DOI 10.4254/wjh.v12.i11.919
  13. McCluskey SA, 2013, ANESTH ANALG, V117, P412, DOI 10.1213/ANE.0b013e318293d81e
  14. McDiarmid SV, 2004, LIVER TRANSPLANT, V10, pS23, DOI 10.1002/lt.20272
  15. Mezones-Holguin Edward, 2019, Braz. J. Nephrol., V41, P501, DOI [10.1590/2175-8239-JBN-2018-0243, 10.1590/2175-8239-jbn-2018-0243]
  16. Nadeem A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0625-7
  17. Oh TK, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2216-5
  18. Palant CE, 2017, CURR OPIN ANESTHESIO, V30, P100, DOI 10.1097/ACO.0000000000000428
  19. Pedoto A, 1999, AM J RESP CRIT CARE, V159, P397, DOI 10.1164/ajrccm.159.2.9802093
  20. Pfortmueller CA, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0174-5
  21. Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305
  22. Rhu J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92298-6
  23. Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584
  24. Silver LJ, 2022, J INTENSIVE CARE MED, V37, P107, DOI 10.1177/0885066620978729
  25. Stenson EK, 2018, PEDIATR CRIT CARE ME, V19, P155, DOI 10.1097/PCC.0000000000001401
  26. Straney L, 2013, PEDIATR CRIT CARE ME, V14, P673, DOI 10.1097/PCC.0b013e31829760cf
  27. Tani M, 2012, SCI WORLD J, DOI 10.1100/2012/474185
  28. Tannuri U, 2014, CLINICS, V69, P42, DOI 10.6061/clinics/2014(Sup01)08
  29. Tornblom S, 2021, ACTA ANAESTH SCAND, V65, P1079, DOI 10.1111/aas.13841
  30. WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820
  31. Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/30
Artigos e Materiais de Revistas Científicas - LIM/36